Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Celerion appoints John Horkulak as Executive Director, Eurasian Site Operations
Celerion appoints John Horkulak as Executive Director, Eurasian Site Operations
Will help expand early phase patient capabilities in Europe and Asia
Lorus Therapeutics completes new executive management team
Lorus Therapeutics completes new executive management team
Avanish Vellanki and Gregory Chow join Canadian biopharmaceutical company as Chief Business Officer and Chief Financial Officer
Aptuit names Jonathan Goldman as Chief Executive
Aptuit names Jonathan Goldman as Chief Executive
He joins the firm from global contract research organisation ICON Clinical Research
Hiroharu Okochi named new President of Harlan Japan
Hiroharu Okochi named new President of Harlan Japan
Harlan says there is growth potential in Asia-Pacific region
Glenmark appoints Philip Andrew Gioia as President North America and Global API Business
Glenmark appoints Philip Andrew Gioia as President North America and Global API Business
He joins the Indian pharmaceutical firm from Bausch & Lomb
Novasep promotes Nadege Laborde to President of Industrial Biotech Business Unit
Novasep promotes Nadege Laborde to President of Industrial Biotech Business Unit
Laborde has been with Novasep since 2000
Theravectys makes two appointments to strengthen executive committee
Theravectys makes two appointments to strengthen executive committee
Hires a Head of Clinical Development and a Head of Strategy and Business Development
Harlan Korea names new President
Harlan Korea names new President
Kwan Goo Edmond (Ed) Cho takes responsibility for Harlan Contract Research Services\' business in Korea
Owen Mumford makes a promotion
Owen Mumford makes a promotion
Modestino Graziano becomes Group Operations Director and joins the Board of Directors
Valeant Pharmaceuticals makes new management appointment
Valeant Pharmaceuticals makes new management appointment
Former McKinsey partner joins the firm in January 2014
Lab M appoints Director of Sales & Marketing
Lab M appoints Director of Sales & Marketing
Wendy Martindale has broad commercial experience in the scientific and laboratory markets
Novo Nordisk and Oxford University join forces to further enhance diabetes research
Novo Nordisk and Oxford University join forces to further enhance diabetes research
Twelve young researchers will be offered a three-year grant to support their research
Dr Gerald Moeller becomes Vice-President of supervisory board at Genticel
Dr Gerald Moeller becomes Vice-President of supervisory board at Genticel
He is a former CEO of the Boehringer Mannheim Group
Eclipse Magnetics appoints separation specialist
Eclipse Magnetics appoints separation specialist
Martyn Cotterill joins metal detection system manufacturer
Camargo Pharmaceutical Services names Jim Beach as Chief Operating Officer
Camargo Pharmaceutical Services names Jim Beach as Chief Operating Officer
He joins the US drug development firm from Cardinal Health
Celerion appoints Clayton Dehn as Executive Director, Metabolic Diseases
Celerion appoints Clayton Dehn as Executive Director, Metabolic Diseases
He joins the company with 15 years of experience in drug development
Previous
1
…
133
134
135
136
(current)
137
138
139
…
213
Next
Trending Articles
Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors
A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
MHRA scientific leader recognised in 2026 King's Birthday Honours
Dr Nicola Rose receives OBE for services to science and public health
Alfa Laval appoints new managing director to drive strategic growth
Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
Servomex appoints new Global Sales Director
Servomex, international expert in gas analysis, has appointed David Jones as Global Sales Director to lead and strengthen its worldwide commercial strategy. Based in the UK head office, David brings more than three decades of experience in management and commercial leadership, along with a strong vision for Servomex at a time of rapid growth in semiconductor manufacturing, tightening emissions regulations, and rising demand for precision gas analysis
Hansa Biopharma appoints Fredrik Röök as VP Business Development
Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will report to CEO Renée Aguiar-Lucander
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all